Description
Femoston Conti (Estradiol/Dydrogesterone) Coated Tablets 1 mg/5 mg. №28
Ingredients
Each tablet contains 1 mg of estradiol and 5 mg of dydrogesterone.
Mechanism of Action
Femoston Conti tablets combine estradiol and dydrogesterone to provide hormone replacement therapy. Estradiol replaces the decreased estrogen levels in postmenopausal women, alleviating menopausal symptoms. Dydrogesterone protects the uterus lining during estrogen therapy.
Pharmacological Properties
Estradiol is a synthetic form of estrogen that binds to estrogen receptors, mimicking the natural hormone’s effects. Dydrogesterone is a progestogen that helps maintain the uterine lining.
Indications for Use
Femoston Conti tablets are indicated for hormone replacement therapy in postmenopausal women to relieve symptoms such as hot flashes and vaginal dryness.
Contraindications
Avoid Femoston Conti if you have a history of breast cancer, blood clots, or liver disease. Consult your healthcare provider before starting this medication.
Side Effects
Common side effects may include nausea, breast tenderness, headache, and vaginal bleeding. Contact your doctor if you experience any severe or persistent side effects.
Usage Instructions
Take one tablet daily with water at the same time each day. The tablet can be taken with or without food. Do not crush or chew the tablet.
Benefits Compared to Analogues
Femoston Conti offers a comprehensive approach to hormone replacement therapy by combining estradiol and dydrogesterone, addressing both estrogen deficiency symptoms and uterine protection in postmenopausal women.
Suitable Patient Groups
Femoston Conti is suitable for postmenopausal women seeking hormone replacement therapy. Consult your doctor for personalized treatment recommendations based on your medical history and individual needs.
Storage and Shelf Life
Store Femoston Conti in a cool, dry place away from direct sunlight. Check the expiration date on the packaging and do not use the tablets if expired.
Packaging Description
Femoston Conti is available in a pack of 28 coated tablets. The packaging should be kept intact and stored as per the storage instructions.
Clinical Evidence and Proven Effectiveness
Research has shown that hormone replacement therapy with estradiol and dydrogesterone effectively manages menopausal symptoms and improves quality of life in postmenopausal women. Studies published in reputable medical journals have highlighted the benefits of hormone therapy in reducing the risk of osteoporosis and cardiovascular disease.
